Alvotech ALVO
NASDAQ ALVO
$5.84 -0.04 (-0.68%)
At close: Sep 22, 2026 · 4:00 PM EDT

Alvotech (ALVO) Non-Current Debt (2020 - 2026)

Alvotech's (ALVO) quarterly Non-Current Debt came in at $1.3 billion in Q2 2026, up 17.9% on a YoY basis from $1.1 billion in Q2 2025, and little changed quarter-over-quarter from $1.3 billion in Q1 2026.

Analysis

Alvotech (ALVO) Non-Current Debt (2020 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Non-Current Debt for 7 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Debt rose 17.9% year-over-year to $1.3 billion; the trailing twelve-month figure through Jun 2026 stood at $1.3 billion (up 17.9% YoY), and the FY2025 full-year result was $1.3 billion, up 21.84% from the prior year.
  • Non-Current Debt steadied at $1.3 billion in Q2 2026 per ALVO's latest filing, from $1.3 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $1.3 billion in Q1 2026 and bottomed at $56.9 million in Q2 2024.
  • Historically, Non-Current Debt has averaged $924.4 million across 5 years, with a median of $1.0 billion in 2024.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Debt tumbled 92.77% in 2024, then surged 1785.01% in 2025.
  • Over 5 years, Non-Current Debt stood at $744.7 million in 2022, then advanced by 23.83% to $922.1 million in 2023, then advanced by 12.34% to $1.0 billion in 2024, then increased by 21.84% to $1.3 billion in 2025, then increased by 0.15% to $1.3 billion in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $1.3 billion, $1.3 billion, and $1.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn 12.09 Bn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn 11.61 Bn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn 150.67 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn 2.57 Bn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn 20.74 Bn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn 280.16 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn 1.26 Bn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn 609.56 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn -
10 NutriBand 94.45 Mn 91.03 Mn 181,874.00 25,099.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.26 Bn
Mar 31, 2026 1.27 Bn
Dec 31, 2025 1.26 Bn
Sep 30, 2025 1.08 Bn
Jun 30, 2025 1.07 Bn
Mar 31, 2025 1.06 Bn
Dec 31, 2024 1.04 Bn
Sep 30, 2024 1.01 Bn
Jun 30, 2024 56.88 Mn
Mar 31, 2024 940.59 Mn
Dec 31, 2023 922.13 Mn
Jun 30, 2023 786.18 Mn
Dec 31, 2022 744.65 Mn
Jun 30, 2022 438.19 Mn
Dec 31, 2021 398.14 Mn
Dec 31, 2020 565.40 Mn
API Access

Alvotech Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ALVO&period=max&api_key=YOUR_API_KEY